ASCO 2020: PROSPER Update Shows Overall Survival Benefit of Enzalutamide in Nonmetastatic Castration-Resistant Prostate Cancer
No new safety concerns were uncovered
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.